HALOPERIDOL REDUCTION CAN BE ASSAYED IN HUMAN RED-BLOOD-CELLS

被引：37

作者：

INABA, T

KALOW, W

SOMEYA, T

TAKAHASHI, S

CHEUNG, SW

TANG, SW

机构：

[1] SHIGA UNIV MED SCI,DEPT PSYCHIAT,OTSU,SHIGA 52021,JAPAN

[2] CLARKE INST PSYCHIAT,PSYCHOPHARMACOL UNIT,TORONTO M5T 1R8,ONTARIO,CANADA

来源：

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 1989年 / 67卷 / 11期

关键词：

D O I：

10.1139/y89-237

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1468 / 1469

页数：2

共 15 条

[1]

ALTAMURA C, 1988, PROG NEURO-PSYCHOPH, V12, P689

[2] QUANTIFICATION OF REDUCED HALOPERIDOL AND HALOPERIDOL BY RADIOIMMUNOASSAY [J].

BROWNING, JL ;

HARRINGTON, CA ;

DAVIS, CM .

JOURNAL OF IMMUNOASSAY, 1985, 6 (1-2) :45-66

[3]

CHANG WH, 1987, BIOL PSYCHIAT, V22, P1406

[4]

CHANG WH, 1989, BIOL PSYCHIAT, V26, P239

[5]

ERESHEFSKY L, 1984, J CLIN PSYCHOPHARM, V4, P138

[6] REVERSED-PHASE LIQUID-CHROMATOGRAPHY FOR THE SEPARATION OF CHLORPROMAZINE, IMIPRAMINE AND SOME OF THEIR METABOLITES [J].

FEKETE, J ;

DELCASTILHO, P ;

KRAAK, JC .

JOURNAL OF CHROMATOGRAPHY, 1981, 204 (JAN) :319-327

[7]

FORSMAN A, 1978, CURR THER RES CLIN E, V24, P567

[8]

INABA T, 1989, DRUG METAB DISPOS, V17, P330

[9] SERUM LEVEL OF HALOPERIDOL AND ITS CLINICAL-SIGNIFICANCE [J].

ITOH, H ;

YAGI, G ;

OHTSUKA, N ;

IWAMURA, K ;

ICHIKAWA, K .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY, 1980, 4 (02) :171-183

[10]

KO GN, 1989, J CLIN PSYCHOPHARM, V9, P186

← 1 2 →